3 matches for your search in the start-up spotlight
rssCFG combines the production of biofuel with the production of biochar and liquid CO2, thus coupling the production of green fuels with the sustainable recycling of CO2 from the atmosphere back into the ecosystem.
TRYPTO THERAPEUTICS is developing a set of novel, proprietary small molecules at TRL level 4 to treat serotonin-related diseases. We have developed and patented a novel class of TPH inhibitors (TPHi) with nanomolar potency in vitro. Our TPHi differ in their scaffold, binding mode, and potency ...